Sileanu Florentina E, Murugan Raghavan, Lucko Nicole, Clermont Gilles, Kane-Gill Sandra L, Handler Steven M, Kellum John A
Center for Critical Care Nephrology and Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Departments of Critical Care Medicine and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania; and.
Center for Critical Care Nephrology and Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Departments of Critical Care Medicine and.
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):187-96. doi: 10.2215/CJN.03200314. Epub 2014 Nov 25.
AKI in critically ill patients is usually part of multiorgan failure. However, nonrenal organ failure may not always precede AKI and patients without evidence of these organ failures may not be at low risk for AKI. This study examined the risk and outcomes associated with AKI in critically ill patients with and without cardiovascular or respiratory organ failures at presentation to the intensive care unit (ICU).
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A large, academic medical center database, with records from July 2000 through October 2008, was used and the authors identified a low-risk cohort as patients without cardiovascular and respiratory organ failures defined as not receiving vasopressor support or mechanical ventilation within the first 24 hours of ICU admission. AKI was defined using Kidney Disease Improving Global Outcomes criteria. The primary end points were moderate to severe AKI (stages 2-3) and risk-adjusted hospital mortality.
Of 40,152 critically ill patients, 44.9% received neither vasopressors nor mechanical ventilation on ICU day 1. Stages 2-3 AKI occurred less frequently in the low-risk patients versus high-risk patients within 24 hours (14.3% versus 29.1%) and within 1 week (25.7% versus 51.7%) of ICU admission. Patients developing AKI in both risk groups had higher risk of death before hospital discharge. However, the adjusted odds of hospital mortality were greater (odds ratio, 2.99; 95% confidence interval, 2.62 to 3.41) when AKI occurred in low-risk patients compared with those with respiratory or cardiovascular failures (odds ratio, 1.19; 95% confidence interval, 1.09 to 1.3); interaction P<0.001.
Patients admitted to ICU without respiratory or cardiovascular failure have a substantial likelihood of developing AKI. Although survival for low-risk patients is better than for high-risk patients, the relative increase in mortality associated with AKI is actually greater for low-risk patients. Strategies aimed at preventing AKI should not exclude ICU patients without cardiovascular or respiratory organ failures.
危重症患者的急性肾损伤(AKI)通常是多器官功能衰竭的一部分。然而,非肾性器官功能衰竭并非总是先于AKI出现,且没有这些器官功能衰竭证据的患者发生AKI的风险可能并不低。本研究调查了入住重症监护病房(ICU)时伴有或不伴有心血管或呼吸器官功能衰竭的危重症患者发生AKI的风险及预后。
设计、地点、参与者及测量方法:使用一个大型学术医疗中心数据库,其记录时间为2000年7月至2008年10月。作者将低风险队列定义为在ICU入院后最初24小时内未接受血管活性药物支持或机械通气的无心血管和呼吸器官功能衰竭的患者。AKI采用改善全球肾脏病预后组织(KDIGO)的标准进行定义。主要终点为中度至重度AKI(2-3期)和风险调整后的医院死亡率。
在40152例危重症患者中,44.9%在ICU第1天既未接受血管活性药物治疗也未接受机械通气。低风险患者在ICU入院后24小时内(14.3%对29.1%)和1周内(25.7%对51.7%)发生2-3期AKI的频率低于高风险患者。两个风险组中发生AKI的患者出院前死亡风险更高。然而,与发生呼吸或心血管功能衰竭的患者相比,低风险患者发生AKI时医院死亡的校正比值比更大(比值比为2.99;95%置信区间为2.62至3.41),而呼吸或心血管功能衰竭患者的比值比为1.19;95%置信区间为1.09至1.3);交互作用P<0.001。
入住ICU时无呼吸或心血管功能衰竭的患者发生AKI的可能性很大。虽然低风险患者的生存率高于高风险患者,但AKI相关的死亡率相对增加在低风险患者中实际上更大。旨在预防AKI的策略不应排除无心血管或呼吸器官功能衰竭的ICU患者。